Myocardial gap junctions: Targets for novel approaches in the prevention of life-threatening cardiac arrhythmias

Physiological Research

Volumn 57, Issue SUPPL. 2, 2008, Pages

  Tribulová, Narcis ^a   Knezl, V ^b   Okruhlicova L' ^a   Slezak J ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Atrial and ventricular fibrillation; Connexin channel; Gap junctions; Therapeutic targets

Indexed keywords

EID: 45949095953     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (73)

1. AXELSEN AN, HAUGAN K, STAHLHUT M, KJØLBYE, HENNAN JK, HOLSTEIN-RATHLOU NH, PETERSEN JS, NIELSEN MS: Increasing gap junctional coupling: A tool for dissecting the role of gap. J Membrane Biol 216: 23-35, 2007.
2. ALLESIE MA, LAMMERS WJEP, BONKE IM, HOLLEN J: Intra-atrial reentry as a mechanism for atrial flutter induced by acetylcholine and rapid pacing in dog. Circulation 70: 123-135, 1984.
3. BACHAROVÁ L: Electrical and structural remodeling in left ventricular hypertrophy- a substrate for a decrease in QRS voltage? A.N.E. 12: 260-273, 2007.
4. BALKE CW, SHOROFSKY SR: Alterations in calcium handling in cardiac hypertrophy and heart failure. Cardiovasc Res 37, 290-299, 1998.
5. BEARDSLEE MA, LERNER DL, TADROS PN, LAING JG, BEYER EC, YAMADA KA, KLÉBER AG, SCHUESSLER RB, SAFFITZ JE: Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res 87: 656-662, 2000.
6. CHEN J, MANDAPATI R, BERENFELD O, SKANES AC, JALIFE J: High frequency periodic sources underlie ventricular fibrillation in the isolated rabbit heart. Circ Res 86: 86-93, 2000.
7. DE BAKER MJT, CAPELLE JL, JANSE MJ, TASSERON S, VERMEULEN JE, DE JONGE N, LAHPOR JR: Slow conduction in the infarcted human heart. "Zigzag" course of activation. Circulation 88: 915-926, 1993.
8. DE GROOT JR, CORONEL R: Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis. Cardiovasc Res 62: 323-334, 2004.
9. 2+ and delay of ischemia-induced electrical uncoupling in preconditioned rabbit ventricular myocardium. Cardiovasc Res 44: 101-102, 1999.
10. 2+ in the control of electrical coupling in the heart fibers. Bioch Biophys Acta 888: 91-99, 1986.
11. De MELLO WC: Cell coupling and healing-over in cardiac muscle. In: Physiology and pathophysiology of the heart. SPERELAKIS N (ed). Kluwer Academic Publisher 541-549, 1989,
12. DHALLA NS, LIU X, PANAGIA V, TAKEDA N: Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res 40: 239-247, 1988.
13. DHEIN S: Gap junction channels in the cardiovascular system: pharmacological and physiological modulation. Trends Pharm Sci 19: 229-241, 1998.
14. FIALOVÁ M, DLUGOSOVÁ K, KNEZL V, OKRUHLICOVÁ L, DRÍMAL J, TRIBULOVÁ N. Omega-3 fatty acids protect male and female aged hypertensive rat heart againts ventricular fibrillation. Acta Physiologica 19, supp.658: 88, 2007.
15. FIALOVÁ M, DLUGOŠOVÁ, OKRUHLICOVÁ L', KRISTEK F, MANOACH M, TRIBULOVÁ N. Adaptation of the heart to hypertension is associated with maladaptive gap junction connexin-43 remodelling. Physiol Res in press (2007a).
16. GARDNER PI, URSEL PC, FENOGLIO JJ, WIT AL: Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation 72: 596-611, 1985.
17. GASPO R, BOSH RF, TALAJIC M, NATTEL S: Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation 96: 4027-4035, 1997.
18. GOODENOUGH DA, GOLIGER JA, PAUL DL: Connexin, connexons and intercellular communication. Annu Rev Biochem 65: 475-502, 1996.
19. GRAY RA, PERTSOV AM, JALIFE J: Spatial and temporal organization during cardiac fibrillation. Nature 392: 75-78, 1999.
20. GUTSTEIN DE, MORLEY GE, TAMADONN H, VAIDYA D, SCHNEIDER MD, CHE J: Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 88:
21. HAGENDORFF A, SCHUMACHER B, KIRCHHOFF S, LUDERITZ B, WILLECKE K: Conduction disturbances and increased atrial vulnerability in Connexin40- deficient mice analyzed by transesophageal stimulation. Circulation 99: 1508-1515, 1999.
22. HANNA IR, HEEKE B, BUSH H, BROSIUS L, KING-HAGMAN D, DUDLEY SC Jr, BESHAI JF, LANGBERG JJ: Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. Heart Rhythm 3: 881-6, 2006.
23. HAUGAN K, OLSEN KB, HARTVIG L, PETERSEN JS, HOLSTEIN_RATHLOU NH, HENNAN JK, NIELSEN MS: The antiarrhythmic peptide analog ZP123 prevents atrial conduction slowing during metabolic stress. J Cardiovsc Electrophysiol 16: 537-545, 2005.
24. HAYACHI H, WANG Ch, MYIAUCHI Y, OMICHI Ch, PAK HN, ZHOU S, OHARA T, MANDEL WJ, LIN SF, FISHBEIN MC, CHEN PS, KARAGUEUZIAN HS: Aging-related increase to inducible atrial fibrillation in the rat model. J Cardiovasc Electrophysiol 13: 801-808, 2002.
25. HOFFMAN BF, ROSEN MR: Cellular mechanisms for cardiac arrhythmias. Circ Res 49: 1-15, 1981.
26. JANSE MJ, DE BAKKER JMT: Arrhythmia substrate and management in hypertrophic cardiomyopathy: from molecules to implantable cardioverter- defibrillators. Europ Heart J 3: 15-20, 2001.
27. JIANG MT, MOFFAT MP, NARAYAN N: Age-related alterations in the phosphorylation of sarcoplasmic reticulum and myofibrillar proteins and diminished contractile response to isoproterenol in intact rat ventricle. Circ Res 72: 102-111, 1993.
28. JOYNER RW: Effect of the discrete pattern of electrical coupling on propagation through an electrical syncytium. Circ Res 50: 192-200, 1982.
29. KIHARA Y, MORGAN JP: Intracellular calcium and ventricular fibrillation. Circ Res 68: 1378-1389, 1991.
30. KOSTIN S, KLEIN G, SZALAY Z, HEIN S, BAUER EP, SCHAPER J: Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 54: 361-379, 2002.
31. LAIRD DW: The life cycle of a connexin: gap junction formation, removal and degradation. J Bioenerg Biomembr 28: 311-317, 1996.
32. LAKATTA EG, GUARNIERI T: Spontaneous myocardial calcium oscillations: are they linked to ventricular fibrillation? J Cardiovasc Electrophysiol l 4: 473-489, 1993.
33. LAMPE PD, LAU AF: Regulation of gap junctions by phosphorylation of connexins. Arch Biochem Biophys 384: 205-215, 2000.
34. LERNER DL, YAMADA KA, SCHUESSLER RB, SAFFITZ JF: Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation 101: 547-552, 2000.
35. MANOACH M, WATANABE Y: How can we facilitate spontaneous termination of ventricular fibrillation and prevent sudden cardiac death? J Cardiovasc Electrophysiol 6: 584-590, 1995.
36. MANOACH M, TRIBULOVÁ N, VOGELEZANG D, THOMAS S, PODZUWEIT T: Transient ventricular fibrillation and myosin heavy chain isoform profile. J Cell Mol Med 11: 171-174, 2007.
37. MERRILAT JC, LAKATTA EG, HANO O, GUARNIERI T: Role of calcium and the calcium channel in the initiation and maintenance of ventricular fibrillation. Circ Res 67: 115-1123, 1990.
38. MUKHERJEER, HERRON AR, LOWRY AS, STROUD RE, STROUD MR, WHARTON JM, IKONOMIDIS JS, CRUMBLEY AJ, SPINALE FG, GOLD MR: Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation. Am J Cardiol 97: 532-537, 2006.
39. OKRUHLICOVÁ L', TRIBULOVÁ N, MIŠEJKOVÁ M, KUKUCKA M, ŠTETKA R, SLEZÁK J, MANOACH M: Gap junction remodelling is involved in the susceptibility of diabetic rats to hypokalemia-induced ventricular fibrillation. Acta Histochemica 104: 387-391, 2002.
40. OLSSON SB: Atrial fibrillation - where we stand today? J Int Med 250: 19-28, 2001.
41. PAPAGEORGIOU P, MONAHAN K, BOYLE NG, SEIFERT MJ, BESWICK P, ZEBEDE J, EPSTEIN LM, JOSEPHSON ME: Site-dependent intra-atrial conduction delay. Circulation 94: 384-389, 1996.
42. PETERS NS, COROMILAS J, SEVERS NJ, WIT AL: Disturbed connexin 43 gap junction distribution correlates with location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 95: 988-996, 1997.
43. POLONTCHOUK L, HAEFLIGER JA, EBELT B, SCHAEFER T, STUHLMANN D, MEHLHORN U, KUHN-REGNIER F, DE VIVIE ER, DHEIN S: Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 38: 883-891, 2001.
44. SAFFITZ JE, SCHUESSLER RB, YAMADA KA: Mechanisms of remodelling of gap junction distribution and the development of anatomic substrates of arrhythmias. Cardiovas Res 42: 309-317, 1999.
45. SALAMEH A, DHEIN S: Pharmacology of gap junctions. New pharmacological targets for treatment of arrhythmia, seizure and cancer? Biochim Biophys Acta 1719: 36-58, 2005.
46. SEVERS NJ: Gap junction remodelling and cardiac arrhythmogenesis: cause or coincidence? J Cell Mol Med 5: 355-366, 2001.
47. SCHULZ R, BOENGLER K, TOTZECK A, LUO Y, GARCIA-DORADO D, HEUSCH G: Connexin 43 in ischemic pre- and postconditioning. Heart Fail Rev12:261-266, 2007.
48. SIMOR T, LORAND T, GASZNER B, ELGAVISH GA: The modulation of pacing-induced changes in intracellular sodium levels by extracellular Ca in isolated perfused rat hearts. J Mol Cell Cardiol 29: 1225-1235, 1997.
49. SPACH MS, HEIDLAGE JF: The stochastic nature of cardiac propagation at a microscopic level. An electrical description of myocardial architecture and its application to conduction. Circ Res 76: 366-380, 1995.
50. SPACH MS, HEIDLAGE JF, DOLBER PC, BARR RC: Electrophysiological effects of remodeling cardiac gap junctions and cell size. Circ Res 86: 302-311, 2000.
51. SPACH MS, KOOTSEY JM, SLOAN JD: Active modulation of electrical coupling between cardiac cells of the dog. A mechanism for transient and steady variations in conduction velocity. Circ Res 51: 347-362, 1982.
52. SPACH MS, STARMER CF: Altering the topology of gap junctions a major therapeutic target for atrial fibrillation. Cardiovasc Res 30: 336-344, 1995.
53. TEUNISSEN BE, JONGSMA HJ, BIERHUIZEN MF: Regulation of myocardial connexins during hypertrophic remodeling. Eur Heart J 25: 1979-89, 2004.
54. TRIBULOVÁ N, DUPONT E, SOUKUP T, OKRUHLICOVÁ L, SEVERS NJ: Sex differences in connexin-43 expression in left ventricles of aging rats. Physiol Res 54: 705-708, 2005.
55. TRIBULOVÁ N, FIALOVÁ M, DLUGOŠOVÁ K, KNEZL V, OKRUHLICOVÁ L, KRISTEK F, ZICHA J, KUNEŠ J. Mzocardial gap junction remodelling in hypetriglyceridemic rat heart is associated with increased vulnerability to ventricular fibrillation. Cardiol 15 (Suppl.1): 32-33S, 2006.
56. + -induced venticular fibrillation while facilitates sinus rhythm restoration in old one. Exper Physiol 89: 629-636, 2004.
57. +-induced ventricular fibrillation. Physiol Res 50: 247-259, 2001.
58. +- induced arrhythmias. Gen Physiol Biophys 22: 369-382, 2003.
59. +- induced lethal arrhythmias in isolated rat heart. Exp Physiol 87: 195-205, 2002.
60. TRIBULOVÁ N, OKRUHLICOVÁ L', VARON D, MANOACH M, PECHANOVÁ O, BERNÁTOVÁ I, WEISMANN P, BARANCÍK M, STYK J, SLEZÁK J: Structural substrates involved in the development of severe arrhythmias in hypertensive rat and aged guinea pig hearts. In: Cardiac Remodeling and Failure, SINGAL P, DIXON I, KIRSCHENBAUM L, DHALLA NS (Eds): Kluwer Academic Publishers, Boston, USA, pp. 377-398, 2002a.
61. 2+ and recovery of intermyocyte coupling precede stobadine-induced ventricular defibrillation in whole heart preparation. Europ Heart J 22: A547, 2001a.
62. TRIBULOVÁ N, VARON D, POLACK-CHARCON S, BUSCEMI P, SLEZÁK J, MANOACH M: Aged heart as a model for prolonged atrial fibrilo-flutter. Exp Clin Cardiol 4: 64-72, 1999.
63. TURNER MS, HAYWOOD GA, ANDREKA P, YOU L, MARTIN PE, EVANS H, WEBSTER KA, BISHOPRIC NH: Reversible connexin 43 dephospohorylation during hypoxia and reoxygenation is linked to cellular ATP levels. Circ Res 95: 726-733, 2004.
64. VAN DER VELDEN HMW, AUSMA J, ROOK MB, HELLEMONS AJCGM, VAN VEEN TAAB, ALLESSIE MA, JONGSMA HJ: Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res 46: 476-486, 2000.
65. WACHTELL K, DEVEREUX RB, LYLE PA: Atrial fibrillation and renin-angiotensin system. Nippon Rinsho 65: 569-74, 2007.
66. WANG YG, HUSER J, BLATTER LA, LIPSIUS S: Withdrawal of acetylcholine elicits Ca-induced delayed afterdepolarizations in cat atrial myocytes. Circulation 96: 1275-1281, 1997.
67. WIJFFELS MCEF, KIRCHHOFF CHJHJ, DORLAND R, ALLESIE A: "AF begets AF" a study in awaked chronically instrumented goats. Circulation 92: 1954-1968, 1995.
68. WINFREE AT: Rotating solutions to reaction diffusion equations in simply connected media. SIAM-AMS Proc 8: 13-31, 1974.
69. WITKOWSKI FX, LEON LJ, PENKOSKE PA, GILES WR, SPANO ML, DITTO WL, WINTRE AT: Spatiotemporal evolution of ventricular fibrillation. Nature 392: 78-82, 1998.
70. ZAITSEV AV, BERENFELD O, MIRONOV SF, JALIFE P, PERTSOV AM: Distribution of excitation frequences on the epicardial and endocardial surfaces of fibrillating ventricular wall of the ship heart. Circ Res 86: 408-417, 2000.
71. ZICHA L, DOBEŠOVÁ Z, KUNEŠ J: Late effects of early intervention: transient captopril treatment of SHR in juvenile critical period for hypertension. Phys Res 55: 5P, 2006.
72. ZICHA L, PECHÁŇOVÁ O, ČAČÁ NYIOVÁ S, CEBOVÁ M, KRISTEK F, TOcombining double acute accentROcombining double acute accentK J, IMKO F, DOBEŠOVÁ Z, KUNEŠ J: Hereditary hypertriglyceridemic rat: A suitable model of cardiovascular disease and metabolic syndrome? Phys Res 55: 49-63, 2006.
73. ZIPES DP, Wellens HJJ: Sudden cardiac death. Circulation 98: 2334-2351, 1998.